Clinical observation of low-dose combination chemotherapy in refractory/recurrent paroxysmal nocturnal hemoglobinuria patients: A single-center retrospective analysis.
Liyan LiHui LiuHonglei WangZhaoyun LiuYingying ChenChunyan LiuXiaoyu ZhaoLijuan LiHuaquan WangZonghong ShaoRong FuPublished in: Journal of clinical laboratory analysis (2022)
Chemotherapy can reduce PNH clones, promote normal hematopoiesis, and control hemolytic attack. It is a promising and widely used therapeutic method.